Примери за използване на Placebo-controlled studies на Английски и техните преводи на Български
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Computer
Placebo-controlled studies.
Results from pivotal placebo-controlled studies.
Four placebo-controlled studies included second season revaccination.
Results from pivotal placebo-controlled studies.
The placebo-controlled studies included studies where linagliptin was given as.
Data derived from pooled placebo-controlled studies.
Double-blind, placebo-controlled studies are considered the most authoritative.
Add-on combination therapy placebo-controlled studies.
In three 26-week, placebo-controlled studies, ertugliflozin reduced systolic blood pressure(SBP).
Summary of key efficacy results from placebo-controlled studies.
In refractory gMG placebo-controlled studies, no antidrug antibodies were observed.
They have not been randomized double-blind, placebo-controlled studies.
Adverse reactions in placebo-controlled studies System organ class.
Clinical Response at Weeks 12, 24, and 52 in Placebo-Controlled Studies.
In three placebo-controlled studies, ertugliflozin resulted in statistically significant reductions in FPG.
There are no double-blind, placebo-controlled studies for this.
The efficacy of YENTREVE has not been evaluated for longer than 3 months in placebo-controlled studies.
Combined results of the 30-week placebo-controlled studies(intent to treat patients).
Sixty of these patients were treated with levetiracetam in placebo-controlled studies.
In the two placebo-controlled studies adverse events were generally mild to moderate in severity.
Adverse reactionsa on ORACEA in pivotal placebo-controlled studies in rosacea.
Table 2: Placebo-controlled studies in combination with metformin(24-week results).
Table 3: Post-treatment ALT Elevations in 2 Placebo-Controlled Studies in Adults.
In the four placebo-controlled studies the hazard ratios for overall survival ranged between 1.25 and 2.47 in favour of controls.
The efficacy of linaclotide has been established in double-blind placebo-controlled studies for up to 6 months.
The three pivotal double-blind placebo-controlled studies included 38 elderly patients aged between 65 and 80 years.
The efficacy of DULOXETINE BOEHRINGER INGELHEIM has not been evaluated for longer than 3 months in placebo-controlled studies.
Detailed prospective, randomized, placebo-controlled studies will be essential for this purpose.
Instead, the safety and efficacy of LIFMIOR were assessed in four randomised,double-blind, placebo-controlled studies.
Similar to the placebo-controlled studies, antibody positivity was associated with reduced efficacy in some patients.